1
|
Abstract
The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over 1200 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy ). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.
Collapse
|
2
|
Mahabadi AA, Lehmann N, Kälsch H, Robens T, Bauer M, Dykun I, Budde T, Moebus S, Jöckel KH, Erbel R, Möhlenkamp S. Association of Epicardial Adipose Tissue With Progression of Coronary Artery Calcification Is More Pronounced in the Early Phase of Atherosclerosis. JACC Cardiovasc Imaging 2014; 7:909-16. [DOI: 10.1016/j.jcmg.2014.07.002] [Citation(s) in RCA: 87] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2014] [Revised: 07/01/2014] [Accepted: 07/03/2014] [Indexed: 10/24/2022]
|
3
|
Frey UH, Moebus S, Möhlenkamp S, Kälsch H, Bauer M, Lehmann N, Nöthen M, Mühleisen TW, Stang A, Erbel R, Jöckel KH, Peters J, Siffert W. GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study. Atherosclerosis 2014; 237:437-42. [PMID: 25463071 DOI: 10.1016/j.atherosclerosis.2014.08.025] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Revised: 07/24/2014] [Accepted: 08/05/2014] [Indexed: 01/08/2023]
Abstract
OBJECTIVE The C825T polymorphism of the gene encoding the human G protein beta-3 subunit (GNB3) is associated with hypertension and obesity. Moreover, genotypes of the GNB3 polymorphism have been associated with development of coronary artery disease, and the 825T allele is thought to influence the process of atherosclerosis. However, the potential of the C825T polymorphism to predict coronary events has been poorly explored in a longitudinal setting at the population level. METHODS In 4159 Caucasian subjects from the Heinz Nixdorf Recall study cohort (age: 45-75 years, 48% male), genotypes of the GNB3 C825T polymorphism (rs5443) were determined and associated with fatal and non-fatal myocardial infarction (hard coronary events). Established cardiovascular risk factors were used to adjust for confounders. RESULTS The median follow-up time was 9.9 years (1st/3rd quartiles 9.5/10.2). 148 subjects (3.6%) experienced a hard coronary event. The 10-year event-free survival rate was CC, 96.1%; CT 96.9%, TT, 93.7% (p = 0.018). Multivariable analysis showed that the TT genotype is a significant risk factor for hard coronary events (hazard ratio (HR) = 1.9 (95% confidence interval (CI) 1.2-2.9); p = 0.008) after adjustment for age, sex, diabetes, systolic blood pressure, body mass index, high-density lipoprotein, and coronary artery calcification as determined by electron beam computed tomography at baseline. While prognosis in females was independent of GNB3 genotypes, analysis in males even elevated the HR for TT versus C-allele to 2.6 (95% CI 1.6-4.2; p < 0.001). CONCLUSION The GNB3 825 TT genotype is a significant and independent risk factor for hard coronary events independent of other established cardiovascular risk factors at a population level in males.
Collapse
Affiliation(s)
- Ulrich H Frey
- Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany.
| | - Susanne Moebus
- Institut für medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| | | | - Hagen Kälsch
- Klinik für Kardiologie, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| | - Marcus Bauer
- Klinik für Kardiologie, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| | - Nils Lehmann
- Institut für medizinische Informatik, Biometrie und Epidemiologie, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| | - Markus Nöthen
- Institut für Humangenetik, Universität Bonn, Germany; Abteilung für Genomik, Life & Brain GmbH, Universität Bonn, Germany
| | - Thomas W Mühleisen
- Institut für Humangenetik, Universität Bonn, Germany; Abteilung für Genomik, Life & Brain GmbH, Universität Bonn, Germany
| | - Andreas Stang
- Institut für klinische Epidemiologie, Medizinische Fakultät, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany; Department of Epidemiology, School of Public Health, Boston University, Boston, USA
| | - Raimund Erbel
- Klinik für Kardiologie, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| | | | - Jürgen Peters
- Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| | - Winfried Siffert
- Institut für Pharmakogenetik, Universität Duisburg-Essen und Universitätsklinikum Essen, Essen, Germany
| |
Collapse
|
4
|
Theilade J, Kanters J, Henriksen FL, Gilså-Hansen M, Svendsen JH, Eschen O, Toft E, Reimers JI, Tybjærg-Hansen A, Christiansen M, Jensen HK, Bundgaard H. Cascade Screening in Families with Inherited Cardiac Diseases Driven by Cardiologists: Feasibility and Nationwide Outcome in Long QT Syndrome. Cardiology 2013; 126:131-7. [DOI: 10.1159/000350825] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2013] [Accepted: 03/17/2013] [Indexed: 01/17/2023]
|